GlassScriptPhysician profile
Andrew J Lemoi
NPI 1114912193
$11,375.57
in general payments reported to CMS, 2019-2025
11 companies · $216 in 2025
The $216 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,442 · 2020: $3,542 · 2021: $278 · 2022: $312 · 2023: $144 · 2024: $442 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $801.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $8,988.02 | 2019-2021 | |
| Smith+Nephew, INC. | $1,134.48 | 2019-2025 | Iodosorb Ointment 40g USA, Collagenase Santyl, Grafix Pl |
| Integra Lifesciences Corporation | $480.05 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Organogenesis INC. | $429.37 | 2019-2022 | |
| Medtronic, INC. | $116.81 | 2024 | Signia |
| Lifenet Health | $109.42 | 2024 | Theragenesis Wound Matrix |
| Osiris Therapeutics INC. | $34.22 | 2019 | |
| Acell, INC. | $29.98 | 2019 | |
| Insmed, INC. | $22.54 | 2025 | Brinsupri, Arikayce |
| Tactile Systems Technology INC | $15.69 | 2025 | Nimbl, Flexitouch Plus |
| Bioventus LLC | $14.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Lemoi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.